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Method and results Glycated serum proteins (GSPs) were quantified at delivery in 612 Chinese mother/child pairs serving as a surrogate of maternal and fetal glycemia. Differential ultrasound examination of the fetal's body (head circumference, biparietal diameter, pectoral diameter, abdominal circumference, and femur length) was done in average 1 week prior to delivery. Multivariable regression analysis considering gestational age at delivery, the child's sex, maternal BMI, maternal age at delivery, maternal body weight, and pregnancyinduced hypertension revealed that fetal GSP was inversely associated with birth weight (R 2 U 0.416; P < 0.001). Fetal GSP was furthermore positively associated with the head-to-abdominal circumference ratio, whereas the maternal GSP was negatively correlated with the offspring's head-to-abdominal circumference ratio (R 2 U 0.285; P U 0.010 and R 2 U 0.261; P U 0.020, respectively). The increased head-to-abdominal circumference ratio in newborns with higher fetal GSP is mainly due to a reduced abdominal circumference rather than reduced growth of the brain.
Conclusion
The disproportional intrauterine growth is in line with the concept of so-called brain sparing, a mechanism maintaining the intrauterine growth of the brain at the expense of trunk growth. Our data suggest that the low birth weight phenotype, linked to cardiovascular diseases like hypertension in later life, might be a phenotype of disproportional intrauterine growth retardation and early life insulin resistance. 
Introduction
Independent epidemiological studies demonstrated the intriguing finding that low birth weight is an important risk factor for glucose intolerance and type 2 diabetes mellitus, as well as other cardiovascular diseases such as myocardial infarction and stroke in later life [1] [2] [3] [4] [5] [6] [7] . Potential mechanisms of this association are still controversial. One possible explanation for this association is intrauterine programming of insulin resistance in response to environmental factors such as maternal malnutrition leading to cardiovascular diseases in later life. On the contrary, it was also suggested that genetically determined insulin resistance results in impaired insulin-mediated growth in the fetus as well as in an insulin resistance phenotype in adult life characterized by cardiovascular diseases such as hypertension, coronary artery disease, peripheral artery disease, and noninsulin-dependent diabetes mellitus (NIDDM) [8, 9] . Insulin resistance probably plays an important role, because it is one of the major underlying causes of glucose intolerance, and its multifaceted consequences include dyslipidemia, hypertension, hypercoagulation, and impaired fibrinolysis [8, 10] . Blunted responses to insulin in small groups of hyperglycemic low birth weight infants have been reported [11] [12] [13] . A recent study in a white population demonstrated that there is an inverse association between total glycated hemoglobin (TGH) of a newborn and its birth weight. The authors concluded that this might be due to increased insulin resistance in newborns with lower birth weight. This study suggests that the pathophysiological mechanisms linking prenatal growth and postnatal sensitivity to insulin are present as early as before birth [14] . The present study was aimed to analyze this phenomenon in more detail by focusing, in addition to birth weight, on anthropometric parameters of the newborn using ultrasound measurements shortly before birth. The current study was done in an Asian cohort using fetal glycated serum proteins (GSPs) as a surrogate of glycemia during the last weeks of pregnancy. A cohort with a different ethnic background as well as a different method to describe glycemic control as a surrogate of insulin resistance (GSP instead of TGH) will give further independent support to the recently published hypothesis that insulin resistance is already present at birth. Moreover -and this is the main focus of the current study -we will for the first time analyze the relation between glycemic control of the newborn at birth and anthropometrics data describing the newborns body shape.
Methods

Clinic data collection
The study was approved by the ethics committee of Jinan University, Guangzhou, China. We invited a total of 810 Chinese women who delivered their babies at the obstetric department of the first affiliated Hospital of Jinan University between March 2010 and October 2010 to participate in the study. Inclusion criteria were as follows: the newborn was born without structural anomalies; singleton pregnancy; no HIV and no syphilis; no drug abuse; and no history of smoking or alcohol consumption during pregnancy. After exclusion of patients who did not fulfill the inclusion criteria, or were not willing to participate, we finally included 612 remaining patients. After obtaining written consent, a structured medical history was taken. Chinese guidelines for medical follow-up in pregnancy comprise the perinatal health manual that contains essential data about the pregnancy. The data in the 'perinatal health manual' were also used to judge whether the women fulfilled all inclusion and exclusion criteria. The following data were extracted into our database: nationality, age, body height, body weight before and during pregnancy, gravidity, parity, gestational age at delivery, smoking before/during pregnancy, alcohol consumption during pregnancy, and blood pressure readings at all follow-up visits. The criteria for diagnosis of pregnancy-induced hypertension according to the Chinese hypertension society is as follows: showing a SBP of 140 mmHg or more and/or a DBP of 90 mmHg or more, taken over a period of 4-6 h after 20 weeks of gestation. The criteria for diagnosis of preeclampsia is the abnormal blood pressure as described above and urinary total protein at least 300 mg in 24 h or urine dipstick indicates at least more than of protein. Gestational age was based on the first day of the last normal menstrual period and confirmed by either first or early second trimester ultrasound scans. Biometric data of the newborns were routinely measured immediately after delivery.
Sample collection and glycated serum protein assay Fetal blood was collected from the umbilical cord within 10 min after delivery. Midwives collected maternal blood from a cubital vein in the delivery room or in the ward before delivery. Probes were processed immediately in 97% of cases. In 18 cases, the staff was not able to process the probes immediately due to emergency circumstances of either the mother or the newborn. In these 18 cases, blood was stored on ice and processed in average 6 h after birth (range 2-18 h). Mean GSP was not different in these probes as compared to the majority of probes (about 97%) processed immediately. The probes were storage at À208C until analysis.
Fetal and maternal blood was analyzed with automatic biochemical analysis instruments. The GlyPro assay (Genzyme, UK; catalog number 950-0608-00) is a specific enzymatic method for the direct measurement of GSP in serum or plasma. The first reagent containing Proteinase K provides an online digestion of the sample and subsequent release of glycated protein fragments. A novel enzyme, ketoamine oxidase (KAO), in the second reagent facilitates the specific oxidation of the ketoamine bond of the glycated protein fragment substrate. Liberation of hydrogen peroxide allows a colorimetric determination of the amount of glycated protein in an endpoint reaction.
Results are obtained by measurement of the increase in absorbance at 550 nm, which is proportional to the concentration of glycated protein in the sample [22, 23] .
Ultrasound measurements during pregnancy All scans were obtained by experienced obstetric physicians in Antenatal Examination Diagnostic Center of the first affiliated Hospital of Jinan University. All the anthropometric parameters of the newborns were measured in two types of three-dimensional ultrasound examination units with internal image analysis software (MEDISON ACCUVIX V20, South Korea and GE VOLUSON 730 EXPERT, USA). Only obstetric physicians who passed the examination for ultrasound diagnostics during pregnancy performed the analysis, ensuring the quality of the data. All examinations were part of the routine examination of pregnant ladies according to the quality standards of the university hospital. The biparietal diameter was measured from the outer edge of the parietal bone near the probe to the inner edge of the other side of the parietal bone at the cross-sectional plane of the fetal brain with major landmarks including the cavum septi pellucidi, thalamus, third ventricle, and ambient cistern. The head circumference was measured in the same plane as the biparietal diameter using the elliptic function of the ultrasound instrument. Abdominal circumference was measured in a plane at the level of the fetal umbilical plexus perpendicular to the spine including the spine, stomach bubble, liver, umbilical vein, the skin, and subcutaneous fat. Femur length was measured from the greater trochanter to the lateral condyle in scans with both bone ends clearly visible. Assessment of pectoral diameter and abdominal diameter were also conducted using standard clinical measurement protocols [15] . All ultrasound parameters are highly significantly (P < 0.001 for each ultrasound parameter) linked to birth weight and normal distribution of ultrasound parameters was verified graphically (data are not shown).
Data analysis
Data were analyzed with SPSS version 19.0 (SPSS Inc., Chicago, Illinois, USA). Results are presented as mean AE standard deviation. Asymptotically normal distribution of birth weight was verified graphically (Fig. 1) . When examining the correlation between GSP and birth weight or ultrasound parameters, variables that are known to influence intrauterine growth and showed a significant bivariate correlation or association with birth weight or ultrasound parameters in our cohort were used as covariables in a multivariable regression analysis. Birth weight and ultrasound parameters, respectively, were treated as the dependent variable and GSP as the independent variable. All variables were entered at the same time. Pearson's correlation coefficient and the regression coefficient B were used to estimate the strength of a correlation. Normality, linearity, and homoscedasticity of residuals were tested and confirmed graphically with residual plots. A P value of less than 0.05 was considered significant.
Results
Description of the cohort
The mean maternal age at delivery was 28.37 AE 3.65 years. The mean BMI before pregnancy was 20.22 AE 2.38 kg/m 2 (for details see Table 1 ). The mean gestational age at delivery was 274.2 AE 9.6 days. The birth weight of the newborns was 3255.87 AE 433.85 g (Fig. 1) . Ultrasound analysis was done on average on gestational day 266.9 AE 14.4 days. Thus, the time between delivery and ultrasound analysis was 7.39 AE 11.66 days (for details see Table 2 ).
By means of bivariate correlation, we could observe a correlation between maternal GSP and maternal weight before pregnancy (P ¼ 0.037), maternal weight at delivery (P ¼ 0.005), and maternal BMI before pregnancy (P ¼ 0.007), which fits into the well known concept of the metabolic syndrome.
Birth weight and glycated serum protein Bivariate correlation analyses and Student's t-tests showed that birth weight was significantly correlated with gestational age at delivery (R ¼ 0.486; P < 0.001), maternal body weight at delivery (R ¼ 0.322; P < 0.001), maternal BMI before pregnancy (R ¼ 0.169; P < 0.001), and maternal age (R ¼ 0.093; P < 0.05), and significantly associated with the sex of the newborn (male 3310.30 g vs. female 3190.90 g; P < 0.001) and pregnancy-induced hypertension [2910.00 (hypertension) vs. 3269.98 (no hypertension); P < 0.05]. It was not significantly correlated with either maternal or the newborn's GSP or with the newborn's GSP-to-maternal GSP ratio. We subsequently examined the correlation between birth weight Number of cases Distribution of birth weight of all 612 newborns with curve for standard distribution. Mean 3255.9 AE 433.9 g, median 3250 g, minimum 1150 g, maximum 4950 g, and skewness À0.331 AE 0.099. and the newborn's GSP, the maternal GSP as well as the newborn's GSP-to-maternal GSP ratio in a multivariable regression analysis considering gestational age at delivery, maternal body weight at delivery, maternal BMI before pregnancy, maternal age, the sex of the newborn, and pregnancy-induced hypertension as co-variables. The newborn's GSP and the newborn's GSP-to-maternal GSP ratio then showed a significant negative correlation with birth weight (P < 0.001 and P < 0.05, respectively). There was no significant correlation between maternal GSP and birth weight. These results did not change when maternal GSP or newborn's GSP were added as an additional confounding factor in the analyses for newborn's or maternal GSP, respectively, or when other models (stepwise conditional enter/remove) were used.
More detailed results of these analyses are displayed in Table 3 .
Ultrasound parameters and glycated serum protein Birth weight shows a significant positive correlation with the following ultrasound parameters: abdominal circumference (R 2 ¼ 0.626; P < 0.001), abdominal diameter (R 2 ¼ 0.539; P < 0.001), head circumference (R 2 ¼ 0.476; P < 0.001), biparietal diameter (R 2 ¼ 0.438; P < 0.00), femur length (R 2 ¼ 0.463; P < 0.001), and pectoral diameter (R 2 ¼ 0.423; P < 0.001). Birth weight was significantly negatively correlated with head-to-abdominal circumference ratio (R 2 ¼ À0.493; P < 0.001), reflecting preferential growth of the head in utero in low birth weight fetuses (Fig. 2) .
In order to perform multivariable regression analyses to investigate the association between ultrasound parameters and GSP, we created bivariate correlation matrices with the variables: gestational day of the ultrasound examination, maternal body weight at delivery, maternal BMI before pregnancy, maternal age, newborn's GSP and maternal GSP, and each ultrasound parameter. A significant correlation between one of the first variables and an ultrasound measurement led directly to the inclusion of this variable as co-variable in the corresponding multivariable regression analysis. The association between each ultrasound parameter and the sex of the newborn was also verified before inclusion of this factor as co-variable. Pregnancy-induced hypertension was always considered in the analysis due to its large effect size and the paucity of cases that did not allow sensitive testing for significance. With that, newborn's GSP showed a significant negative correlation with abdominal circumference, biparietal diameter, femur length and pectoral diameter, and a significant positive correlation with the head circumference-to-abdominal circumference ratio (Table 4) . Maternal GSP was not significantly correlated with any of the primary ultrasound measurements, but showed a significant negative correlation with the head circumference-to-abdominal circumference ratio, whereas the newborn's GSP-toDisproportional intrauterine growth retardation and early life insulin resistance Li et al. 1715 Table 3 Multivariable regression analysis of the association between birth weight and glycated serum proteins 
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For the GSPs of the newborn, the mother, and the quotient of the two, results of a multivariable regression analysis with birth weight as the dependent variable are shown. B, nonstandardized regression coefficient; GSPs, glycated serum proteins; HTN, hypertension.
maternal GSP ratio was significantly positively correlated with the head circumference-to-abdominal circumference ratio. Detailed numerical data of these results are displayed in Table 4 .
When using GSP as the dependent and birth weight/ ultrasound measurements as independent the variable, the associations we could observe were the same as those presented in Tables 3 and 4 (data not shown), indicating the robustness of the findings. Furthermore, in this study, we had 32 preterm birth cases (birth at <37 weeks of gestation). Excluding these cases from the study population does not influence the main findings described in Tables 3 and 4 (data not shown).
Validation of glycated serum protein for the analysis of glycemic control According to Chinese guidelines, oral glucose tolerance tests were performed in the second trimester of pregnancy to screen for gestational diabetes mellitus. We used this for validation of the GSP data set. Both maternal GSP and fetal GSP were significantly correlated with the results of the oral glucose tolerance test in the second trimester, fasting blood glucose (P ¼ 0.008, P ¼ 0.002, respectively), 1 h after oral glucose (P ¼ 0.008, P ¼ 0.016, respectively), and 2 h after oral glucose (P ¼ 0.018, P ¼ 0.039, respectively).
The results of the multivariable models were consistent when mothers with abnormal blood glucose level and their children were excluded from the analyses, apart from the exception that the late-term femur length was significantly negatively correlated with the child-tomother GSP ratio (data not shown).
Discussion
We demonstrated in a large Asian study population an inverse relationship between GSPs of a newborn and its birth weight. This is in line with findings in a white cohort [14] . We demonstrated here, furthermore, an inverse relation between fetal concentrations of GSP and anthropometric parameters like fetal abdominal circumference. Moreover, we were able to link the head-to-abdominal circumference ratio with fetal concentrations of GSP. GSP was quantified as a surrogate of fetal glycemia, which possibly reflects insulin resistance. Our data suggest that the low birth weight phenotype, linked to cardiovascular diseases like hypertension in later life, might be a phenotype of disproportional intrauterine growth retardation and early life insulin resistance.
The cohort studied here is representative in terms of key characteristics for a Chinese cohort like maternal age, maternal height, maternal BMI before pregnancy, gestational age, and birth weight [16, 17] , suggesting that our findings are of general impact. Head circumference-to-abdominal circumference ratio in relation to birth weight. Scatter plot with regression line and 95% confidence interval of the mean. The correlation coefficient and probability value from bivariate regression analysis are given. GSPs, glycated serum proteins. For each ultrasound measurement, three multivariable regression analyses were performed, with the ultrasound measurement being the dependent variable and each of the GSP values being the independent variable. Variables that had shown a significant correlation with the ultrasound measurement in bivariate correlation analysis were included as co-variables (values not displayed here). Shown are the R 2 , B and P values for the GSP measurements. B, nonstandardized regression coefficient; GSPs, glycated serum proteins.
M Statistically significant.
reducing sugars described as a Millard reaction. This occurs when amino acids combine with glucose to form labile Schiff bases, which, over time, are converted to stable kleptomanias by an Amador rearrangement. Instances wherein blood glucose levels are elevated, the concentration of glycated serum proteins also increases. Measurement of glycated serum protein is representative of the mean blood glucose levels over the preceding 2-3 weeks, which is the mean half-life of the serum protein [18, 19] . It is unaffected by acute glucose changes after food or intravenous glucose administration [20] . Measuring simply insulin concentration is not suitable for our topic, because this rather reflects glycemic control affected by labor when giving birth [21] . Measurements of GSP were recently associated with insulin resistance in adults [18, 22, 23] , thus we decided to use this method for our study, as more invasive methods to analyze real insulin resistance in newborns such as clamp techniques are not acceptable from an ethical point of view. Although measurements of GSP were recently associated with insulin resistance, see above, our data could also be explained by a reduced secretion of insulin. Lower intrauterine insulin concentrations may affect fetal growth also in an organ-specific manner. However, as insulin clamp techniques are ethically not feasible in otherwise healthy newborns, this aspect needs to be addressed in adequately designed animal studies.
Fetal GSP is positively related to maternal GSP (data not shown), but have opposite effects on fetal growth as indicated for example by the opposite findings concerning the head-to-abdominal circumference ratio or simply the abdominal circumference, see Table 4 . This seeming contradiction is only possible, as the determination of fetal growth parameters like the head-to-abdominal circumference ratio is multifactorial and the correlations with maternal and fetal GSP only accounts for a small proportion of its variance. Similar findings were reported earlier by Pfab et al. [14] with respect to the opposite effects of maternal and fetal total glycated hemoglobin on birth weight in a white population, see also the correspondence to this study.
Anthropometric parameters may be influenced by labor especially for head circumference [24] . The anthropometric parameters were measured by ultrasound some days prior to birth. Thus, these values are not influenced by labor when giving birth and, hence, are reliable.
When fetal growth is restricted, the human fetus maintains the brain at the expense of growth of the trunk, a well studied observation called 'brain sparing' [25] . The liver may be particularly compromised. In this case, the abdominal circumference-to-head circumference ratio is less than normal. The head-to-abdominal circumference ratio could be adopted to separate symmetric growth from asymmetrical growth in clinic [15] . Our data indicate that the higher head-to-abdominal circumference ratio in newborns with higher fetal serum glycated protein concentrations is driven by a relatively lower abdominal circumference. Our data thus indicate that higher GSP concentrations were related to asymmetrical growth of the fetus in late gestation. This fits with the concept that under conditions of shortness of nutrition during pregnancy the brain is preferentially supplied with nutrition [26] . The underlying molecular mechanisms are not fully understood. We suggest that this might be due to an organ-specific alteration of insulin resistance and put the forward hypothesis that one molecular mechanism of brain sparing in humans under less favorable environmental condition during pregnancy is the development of an organ-specific insulin resistance. Growth of key organs for survival -like the brain -may be less affected by insulin resistance as compared with organs that are somewhat less important. As insulin is a growth factor during intrauterine life, organ-specific insulin resistance may lead to different organ growth. The net result of such a mechanism is an increased head-to-abdominal circumference ratio in newborns.
The mechanisms of the association between insulin resistances at birth and fetal growth are controversial. The hypothesis of Barker and Bagby [9] on the developmental origins postulates that tissues are permanently influenced by the intrauterine environment ('developmental plasticity', insulin resistance, hence, might be an acquired phenotype), whereas Hattersley and Tooke [8] proposed that low birth weight, glucose intolerance, and diabetes mellitus might all be the phenotypes of the same insulin-resistant genotype. In any case, the current study suggests that the phenotype of neonatal insulin resistance is not just low birth weight but also disproportional intrauterine growth due to brain sparing. In line with our data is a recent study in an animal model of intrauterine growth retardation (IUGR) showing organ-specific effects on the expression of glucose transporters facilitating a better glucose transport to the growing brain, as compared with other tissues. In other words, this animal model showed an organ-specific alteration of insulin resistance as a potential mechanism of brain sparing [27] .
Recent studies demonstrated a strong correlation between fetal liver volume, gestational age, and fetal biometric parameters (abdominal circumference and others) [28, 29] . Therefore, reduced abdominal circumference is mainly reflecting reduced liver size. An animal model of IUGR by uterine artery ligation was likewise characterized by low birth weight, lower liver weight, and lower liver glycogen storage [30] .
Support for an important role for liver development in the early pathogenesis of coronary heart disease comes from findings in Sheffield. Among men and women, reduced abdominal circumference at birth, a measure that reflects reduced liver size, gave stronger predictions of later serum cholesterol and plasma fibrinogen than any other measure of body size at birth. Our study is the first to link increased head-to-abdominal circumference ratio and a surrogate of reduced liver size in early life to insulin resistance in early life in humans. Growth restriction of the liver seems to have several adverse long-term effects. It was reported that having a relatively small liver at birth contributes to higher low-density lipoprotein (LDL) plasma concentrations in later life. The processes by which impaired liver growth in late gestation could permanently change the metabolism of LDL cholesterol are unknown. A study of LDL metabolism in samples of middle-aged men in five countries, however, led to the suggestion that differences in serum concentrations depend on different activity of LDL receptors in the liver [31] .
In conclusion, our study suggests that insulin resistance as assessed by measuring fetal glycated serum protein is already present at birth and is associated with low birth weight as well as an increased head-to-abdominal circumference ratio, a parameter describing asymmetrical intrauterine growth. As increased fetal serum glycated protein concentrations were seen in newborns with increased head-to-abdominal circumference ratio, we suggest that insulin resistance -acquired by environmental factors or inborn -might be one of the underlying mechanisms leading to brain sparing.
